We are pleased to announce Faron has joined a research consortium that has received a United States Department of Defense (DoD) Grant to investigate the use of Traumakine®, our intravenous interferon beta-1a therapy, in preventing ischemia-reperfusion injury in battlefield victims when using a lifesaving torniquet. To read more, visit: https://lnkd.in/eKub9r7r #Faron #Biotech #drugdevelopment
Congrats Juho and the team! That's wonderful news! Traumakine really deserves this opportunity and more 🎉🤩
💪🏻💪🏻
Congratulations Juho Jalkanen MD, PhD and Faron on the DoD grant / nondilutive capital
Congrats Juho and whole Faron team!
Great news!
Chief Project Manager at Lamus Inc.
1wGreat News ; I’m proud of your team and of all efforts for this novel therapy!